explore
Previous article:
Psychedelics group wrestles with new pharma identity
Next article: AstraZeneca bets AAV gene therapy will still deliver the goods
Next article: AstraZeneca bets AAV gene therapy will still deliver the goods
focus
knowledge
-
For longer
2025-09-03 14:38 -
ASCO eve: Let’s set the table for this year's meeting
2025-09-03 14:23 -
Digital health: a case of mistaken identity
2025-09-03 13:00 -
At flashy new research hub, AstraZeneca lays out ambitious growth goals
2025-09-03 12:59 -
In science, is the line between industry and academia shifting?
2025-09-03 12:58 -
Apellis safety probe of eye disease drug centers on injection needle
2025-09-03 12:37